Phase II-III Clinical Research Services

Accelerating Clinical Research with a Suite of Comprehensive Services

Our in-house medical, regulatory and operational experts work collaboratively to support your Phase IIb-III clinical trials. We combine scientific leadership with disciplined execution, global access to patients, and local and global regulatory expertise to accelerate your compound to approval.

Full-time physicians provide strategic direction for study design and planning, train operations staff, work with primary investigators, provide medical monitoring, and meet with regulatory agencies
Strategic regulatory leadership guides trial design and execution recommendations
Long-standing interactions at the medical and operational levels with global key academic opinion leaders and key sites including preferred CRO status at specific sites
Close collaborations and ongoing programs with high recruiting sites at academic, network, and independent centers
Dedicated global regulatory submissions teams experienced in key therapeutic and specialty area trial application processes and site start-up
In-house contract attorneys to expedite contract negotiations and final execution
Proprietary, integrated clinical study management technology platform facilitates efficient execution of global trials
Experienced in Data Safety Monitoring Committee management as well as providing ongoing statistical support
Detailed country and site selection processes to use the best site mix for the program as well as ongoing tracking and site communication to maintain trial timelines
Focused teams permit Medpace to address each program’s specific needs and to provide consistent operational excellence
Comprehensive and rigorous internal training program for CRAs